|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 308 for F8

<< First    < Previous  |  Next >    Last >>
0.047s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: chimpanzee
Gene
Type: gene
Organism: dog, domestic
Gene
Type: gene
Organism: cattle
Gene
Type: gene
Organism: chicken
Gene
Type: gene
Organism: zebrafish
Gene
Type: gene
Organism: macaque, rhesus
Gene
Type: gene
Organism: frog, western clawed
Gene
Type: gene
Organism: rat
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Gene
Type: gene
Organism: human
Allele  
Name: f8 gastrulation arrest
Allele Type: Chemically induced (ENU)
Publication
First Author: Zhang JP
Year: 2019
Journal: Genome Biol
Title: Curing hemophilia A by NHEJ-mediated ectopic F8 insertion in the mouse.
Volume: 20
Issue: 1
Pages: 276
Cell Line
Name: F8
Derivation . Parent Cell Line . Name: D3H
Cell Line Type: ES Cell
Publication
First Author: Chao BN
Year: 2016
Journal: J Thromb Haemost
Title: Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene.
Volume: 14
Issue: 2
Pages: 346-55
Heritable Phenotypic Marker
Type: heritable_phenotypic_marker
Organism: mouse, laboratory
Protein Domain
Type: Family
Description: This family consists of several poxvirus F8 proteins. The function of this family is unknown.
GXD Expression      
Probe: MGI:2179073
Assay Type: RT-PCR
Annotation Date: 2002-05-15
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1603911
Stage: TS11
Assay Id: MGI:2179079
Age: embryonic day 7.5
Specimen Label: F8
Detected: true
Specimen Num: 1
GXD Expression      
Probe: MGI:2179073
Assay Type: RT-PCR
Annotation Date: 2002-05-15
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3568928
Stage: TS28
Assay Id: MGI:2179080
Age: postnatal adult
Specimen Label: F8
Detected: true
Specimen Num: 1
GXD Expression      
Probe: MGI:2681703
Assay Type: RT-PCR
Annotation Date: 2003-12-19
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1757728
Stage: TS28
Assay Id: MGI:2681778
Age: postnatal day 21
Specimen Label: F8
Detected: true
Specimen Num: 6
GXD Expression      
Probe: MGI:2681702
Assay Type: RT-PCR
Annotation Date: 2003-12-19
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1757728
Stage: TS28
Assay Id: MGI:2681779
Age: postnatal day 21
Specimen Label: F8
Detected: true
Specimen Num: 6
GXD Expression      
Probe: MGI:2681701
Assay Type: RT-PCR
Annotation Date: 2003-12-19
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1757728
Stage: TS28
Assay Id: MGI:2681780
Age: postnatal day 21
Specimen Label: F8
Detected: true
Specimen Num: 6
Publication
First Author: Hayakawa M
Year: 2021
Journal: Sci Rep
Title: Characterization and visualization of murine coagulation factor VIII-producing cells in vivo.
Volume: 11
Issue: 1
Pages: 14824
Publication
First Author: van Helden PM
Year: 2011
Journal: Blood
Title: Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model.
Volume: 118
Issue: 13
Pages: 3698-707
Publication
First Author: Greene TK
Year: 2010
Journal: Blood
Title: In vivo efficacy of platelet-delivered, high specific activity factor VIII variants.
Volume: 116
Issue: 26
Pages: 6114-22
Gene
Type: gene
Organism: zebrafish
Publication
First Author: Everett LA
Year: 2014
Journal: Blood
Title: Murine coagulation factor VIII is synthesized in endothelial cells.
Volume: 123
Issue: 24
Pages: 3697-705
Publication
First Author: Westrick RJ
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Sensitized mutagenesis screen in Factor V Leiden mice identifies thrombosis suppressor loci.
Volume: 114
Issue: 36
Pages: 9659-9664
Protein
Organism: Mus musculus/domesticus
Length: 2247  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 2249  
Fragment?: false
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus caroli
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus
Publication
First Author: Elder B
Year: 1993
Journal: Genomics
Title: Sequence of the murine factor VIII cDNA.
Volume: 16
Issue: 2
Pages: 374-9
Publication
First Author: Ragni MV
Year: 2009
Journal: Exp Hematol
Title: Factor VIII-pulsed dendritic cells reduce anti-factor VIII antibody formation in the hemophilia A mouse model.
Volume: 37
Issue: 6
Pages: 744-54
Publication
First Author: Follenzi A
Year: 2012
Journal: Blood
Title: Role of bone marrow transplantation for correcting hemophilia A in mice.
Volume: 119
Issue: 23
Pages: 5532-42
Publication
First Author: Zhang AH
Year: 2018
Journal: J Immunol
Title: Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells.
Volume: 201
Issue: 5
Pages: 1434-1441
Publication
First Author: Bi L
Year: 1995
Journal: Nat Genet
Title: Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.
Volume: 10
Issue: 1
Pages: 119-21
Publication
First Author: Shi Q
Year: 2008
Journal: Blood
Title: Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity.
Volume: 112
Issue: 7
Pages: 2713-21
Publication
First Author: Bi L
Year: 1996
Journal: Blood
Title: Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies.
Volume: 88
Issue: 9
Pages: 3446-50
Publication
First Author: Wroblewska A
Year: 2012
Journal: Blood
Title: Modification of an exposed loop in the C1 domain reduces immune responses to factor VIII in hemophilia A mice.
Volume: 119
Issue: 22
Pages: 5294-300
Publication
First Author: Allacher P
Year: 2011
Journal: Blood
Title: Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9.
Volume: 117
Issue: 1
Pages: 259-67
Publication
First Author: Ward NJ
Year: 2011
Journal: Blood
Title: Codon optimization of human factor VIII cDNAs leads to high-level expression.
Volume: 117
Issue: 3
Pages: 798-807
Publication
First Author: Chen Y
Year: 2016
Journal: Blood
Title: The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunity.
Volume: 127
Issue: 10
Pages: 1346-54
Publication
First Author: Nielsen AL
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Engineering of a membrane-triggered activity switch in coagulation factor VIIa.
Volume: 114
Issue: 47
Pages: 12454-12459
Publication
First Author: Pordes AG
Year: 2011
Journal: Blood
Title: T cell-independent restimulation of FVIII-specific murine memory B cells is facilitated by dendritic cells together with toll-like receptor 7 agonist.
Volume: 118
Issue: 11
Pages: 3154-62
Publication
First Author: Lipshutz GS
Year: 1999
Journal: Proc Natl Acad Sci U S A
Title: Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero.
Volume: 96
Issue: 23
Pages: 13324-9
Publication
First Author: Steinitz KN
Year: 2012
Journal: Blood
Title: CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.
Volume: 119
Issue: 17
Pages: 4073-82
Publication
First Author: Lai JD
Year: 2016
Journal: Blood
Title: Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A.
Volume: 127
Issue: 26
Pages: 3439-49
Publication
First Author: Sehgal A
Year: 2015
Journal: Nat Med
Title: An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia.
Volume: 21
Issue: 5
Pages: 492-7
Publication  
First Author: Mashausi DS
Year: 2022
Journal: Biochem Biophys Res Commun
Title: A high efficient FVIII variant corrects bleeding in hemophilia A mouse model.
Volume: 637
Pages: 358-364
Publication
First Author: Siner JI
Year: 2013
Journal: Blood
Title: Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype.
Volume: 121
Issue: 21
Pages: 4396-403
Publication
First Author: Xu D
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Phenotypic correction of murine hemophilia A using an iPS cell-based therapy.
Volume: 106
Issue: 3
Pages: 808-13
Publication
First Author: Ferrière S
Year: 2020
Journal: Blood
Title: A hemophilia A mouse model for the in vivo assessment of emicizumab function.
Volume: 136
Issue: 6
Pages: 740-748
Publication
First Author: Fakharzadeh SS
Year: 2000
Journal: Blood
Title: Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin.
Volume: 95
Issue: 9
Pages: 2799-805
Publication
First Author: Evans GL
Year: 1998
Journal: Proc Natl Acad Sci U S A
Title: Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A.
Volume: 95
Issue: 10
Pages: 5734-9
Publication
First Author: Milanov P
Year: 2012
Journal: Blood
Title: Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
Volume: 119
Issue: 2
Pages: 602-11
Publication
First Author: Sack BK
Year: 2012
Journal: PLoS One
Title: Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy.
Volume: 7
Issue: 5
Pages: e37671
Publication
First Author: Purohit VS
Year: 2005
Journal: J Biol Chem
Title: Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-L-serine complex.
Volume: 280
Issue: 18
Pages: 17593-600
Publication
First Author: Matsui H
Year: 2014
Journal: PLoS One
Title: Delivery of full-length factor VIII using a piggyBac transposon vector to correct a mouse model of hemophilia A.
Volume: 9
Issue: 8
Pages: e104957
Publication
First Author: Waters B
Year: 2009
Journal: Blood
Title: Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response.
Volume: 113
Issue: 1
Pages: 193-203
Publication
First Author: Kiouptsi K
Year: 2017
Journal: PLoS One
Title: Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels.
Volume: 12
Issue: 8
Pages: e0183590
Publication
First Author: Muczynski V
Year: 2018
Journal: Blood
Title: A factor VIII-nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation.
Volume: 132
Issue: 11
Pages: 1193-1197
Publication
First Author: Neyman M
Year: 2008
Journal: Blood
Title: Analysis of the spatial and temporal characteristics of platelet-delivered factor VIII-based clots.
Volume: 112
Issue: 4
Pages: 1101-8
Publication
First Author: Rossi G
Year: 2001
Journal: Blood
Title: Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A.
Volume: 97
Issue: 9
Pages: 2750-7
Publication
First Author: Brown BD
Year: 2004
Journal: J Thromb Haemost
Title: Factors influencing therapeutic efficacy and the host immune response to helper-dependent adenoviral gene therapy in hemophilia A mice.
Volume: 2
Issue: 1
Pages: 111-8
Publication
First Author: Eubanks J
Year: 2016
Journal: Blood
Title: A subset of high-titer anti-factor VIII A2 domain antibodies is responsive to treatment with factor VIII.
Volume: 127
Issue: 16
Pages: 2028-34
Publication  
First Author: Peyron I
Year: 2018
Journal: Cell Immunol
Title: Oxidation of factor VIII increases its immunogenicity in mice with severe hemophilia A.
Volume: 325
Pages: 64-68
Publication
First Author: Leong L
Year: 2015
Journal: Blood
Title: Noncovalent stabilization of the factor VIII A2 domain enhances efficacy in hemophilia A mouse vascular injury models.
Volume: 125
Issue: 2
Pages: 392-8
Publication
First Author: Magisetty J
Year: 2022
Journal: Blood
Title: Selective inhibition of activated protein C anticoagulant activity protects against hemophilic arthropathy in mice.
Volume: 139
Issue: 18
Pages: 2830-2841
Publication
First Author: McIntosh J
Year: 2013
Journal: Blood
Title: Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.
Volume: 121
Issue: 17
Pages: 3335-44
Publication
First Author: Tatsumi K
Year: 2013
Journal: PLoS One
Title: A novel cell-sheet technology that achieves durable factor VIII delivery in a mouse model of hemophilia A.
Volume: 8
Issue: 12
Pages: e83280
Publication
First Author: Matsui H
Year: 2009
Journal: Blood
Title: A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cells.
Volume: 114
Issue: 3
Pages: 677-85
Publication  
First Author: Krishnamoorthy S
Year: 2016
Journal: Cell Immunol
Title: Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice.
Volume: 301
Pages: 30-9
Publication  
First Author: Zhang AH
Year: 2016
Journal: Cell Immunol
Title: Tolerogenic nanoparticles to induce immunologic tolerance: Prevention and reversal of FVIII inhibitor formation.
Volume: 301
Pages: 74-81
Publication
First Author: Sherman A
Year: 2014
Journal: Blood
Title: Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells.
Volume: 124
Issue: 10
Pages: 1659-68
Publication
First Author: Qian J
Year: 2000
Journal: Blood
Title: Prevention and treatment of factor VIII inhibitors in murine hemophilia A.
Volume: 95
Issue: 4
Pages: 1324-9
Publication
First Author: Bril WS
Year: 2006
Journal: Thromb Haemost
Title: Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitution.
Volume: 95
Issue: 2
Pages: 341-7
Publication
First Author: Mishra A
Year: 2018
Journal: Int J Exp Pathol
Title: Evaluation of high-fat high-fructose diet treatment in factor VIII (coagulation factor)-deficient mouse model.
Volume: 99
Issue: 1
Pages: 46-53
Publication
First Author: Staber JM
Year: 2016
Journal: PLoS One
Title: Shortened Lifespan and Lethal Hemorrhage in a Hemophilia A Mouse Model.
Volume: 11
Issue: 5
Pages: e0154857
Publication
First Author: Sen D
Year: 2013
Journal: J Thromb Haemost
Title: Nuclear factor (NF)-κB and its associated pathways are major molecular regulators of blood-induced joint damage in a murine model of hemophilia.
Volume: 11
Issue: 2
Pages: 293-306
Publication
First Author: Bhatt S
Year: 2015
Journal: Exp Hematol
Title: Hepatic stellate cell-conditioned myeloid cells provide a novel therapy for prevention of factor VIII antibody formation in mice.
Volume: 43
Issue: 4
Pages: 277-85
Publication
First Author: Ohlfest JR
Year: 2005
Journal: Blood
Title: Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system.
Volume: 105
Issue: 7
Pages: 2691-8
Publication
First Author: Cooke EJ
Year: 2023
Journal: J Thromb Haemost
Title: Maladaptive lymphangiogenesis is associated with synovial iron accumulation and delayed clearance in factor VIII-deficient mice after induced hemarthrosis.
Volume: 21
Issue: 9
Pages: 2390-2404